<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_San_Andres_Software skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:San Andres/Software</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&lt;endnote&gt;&lt;head&gt;&lt;title&gt;&lt;endnote&gt;&lt;head&gt;&lt;meta&gt;&lt;title&gt;</TITLE><TITLE>wiki</TITLE><TITLE>wiki</TITLE><TITLE>exp</TITLE><TITLE>wiki</TITLE><TITLE>wiki</TITLE><TITLE>wiki 2</TITLE>Â <TABLE style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-15ao"><TBODY><TR heigth="75px"><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres" style="color: rgb(0, 0, 0);">Home </A></TD><TD style="border: 3px solid black;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Team" style="color: rgb(0, 0, 0);"> Team</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Description" style="color: rgb(0, 0, 0);"> Project</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Parts" style="color: rgb(0, 0, 0);"> Parts</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Modeling" style="color: rgb(0, 0, 0);"> Modeling</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Results" style="color: rgb(0, 0, 0);"> Results</A></TD></TR></TBODY></TABLE><TABLE style="width: 968px; height: 34px;" class="gwd-table-nb4m editable gwd-table-10nh"><TBODY><TR heigth="75px"><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Notebook" style="color: rgb(0, 0, 0);">Notebook</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Practices" style="color: rgb(0, 0, 0);"> Human Practices</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Design" style="color: rgb(0, 0, 0);"> Future Projections</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Attributions" style="color: rgb(0, 0, 0);"> Attributions</A></TD><TD style="border: 3px solid #1d1003;" align="center" bgcolor="#ffee1b" height="30" onmouseout="this.bgColor='#ffee1b'" onmouseover="this.bgColor='#6bb402'"><A href="https://2015.igem.org/Team:San_Andres/Collaborations" style="color: rgb(0, 0, 0);"> Collaborations</A></TD></TR></TBODY></TABLE></P><DIV class="gwd-div-7xzo gwd-a-1thu"><H1>Abstract</H1><DIV style="text-align: justify;"><BIG>The celiac
disease affects 1 in 265 people worldwide and 15%
of population in Chile. This in an irreversible autoimmune disease in
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
affected, the consumption of foods containing gluten (all fods derived
from wheat, barley, rye, etc.) cause an inflammation in small intestine
causing multiple effects in the organism (diarrhea, constipation, porr
absorption, among others) significantly affecting their quatily of life.</BIG><BIG>Whereas the majority of the world food contains gluten, we
propose a
treatment for those who can't eat gluten, and can do so without
problems. In detail, our project involves a system able to degrade
gluten via the enzyme KumaMax and report the operation simultaneously
with a red fluorescent protein. The foregoing, works in a genetically
modified E. coli bacteria. With this project, in long run, we hope to
improve the quality of life of all those reported with celiac disease.
People who suffer from gluten intolerance have an adverse reaction to
gluten proteins found in wheat, barley, and rye products.</BIG></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>